Altimmune, Inc. · NASDAQ:ALT
The Vanguard Group reported a 9.09% stake in Altimmune, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 9.09% stake in Altimmune, Inc., 9,491,159 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 9.09%
- Shares
- 9,491,159
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 9.09% | 9,491,159 |
Source
Related
- Altimmune, Inc.
- The Vanguard Group
- Altimmune, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Weaver Gregory L · Oct 5, 2026
- Form 4 · Arbet-Engels Christophe · Oct 5, 2026
- Form 4 · Richardson Linda M · Sep 17, 2026
- Form 4 · Durso Jerome Benedict · Aug 13, 2026
- Form 4 · Roberts M Scot · Aug 3, 2026